Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Pharm Res. 2013 Jun 13;30(8):1947–1955. doi: 10.1007/s11095-013-1036-1

Table III.

Number of micropores created for each treatment group and the gels applied to the skin.

Group Total number of micropores Gels applied In vitro flux of NTX•HCl, nmol/cm2•hr Predicted [NTX], plasma (ng/ml) Actual [NTX], plasma (ng/ml) Actual [NTX] + [NTXol], plasma (ng/ml)
1 800 (8 patches) Diclofenac + NTX 42.58 ± 7.88 (n = 3) 4 1.2 (0.3) 3.18 (0.7)
2 200 (2 patches) Placebo + NTX 170.84 ± 32.12 (n = 3) 4 1.1 1.19
3 NA Diclofenac + NTX NA 0 0 0